A A Email Print Share

Duquesne Center for Pharmaceutical Technology

Director: Carl A. Anderson, Ph.D.

About The Center

The Duquesne University Center for Pharmaceutical Technology (DCPT) focuses on improving the safety, quality and efficiency of pharmaceutical manufacturing through the application of relevant technology. The Center functions as a point of convergence for the research interests of faculty and those of collaborators who develop technology related to pharmaceutical manufacturing. It works to address major issues within this field, such as regulatory concerns, science-based methods of validation and business advantages of technology. Clients and collaborators of the Center include representatives from industry, other academic institutions, regulatory authorities, equipment vendors and private consultants.

Objectives

The mission of the Duquesne University Center for Pharmaceutical Technology (DCPT) is the advancement of pharmaceutical manufacturing through the application of appropriate technologies for the improvement of safety, quality and efficiency throughout the pharmaceutical industry.


Services

The Center's research addresses the major issues of regulatory concerns, science-based methods validation and business advantages of technology. Participants (clients and collaborators) in the center include representatives from industry, other academic institutions, regulatory authorities, equipment vendors and private consultants.

Personnel
Anderson

Carl A. Anderson, Ph.D.

Center Director
Associate Professor of Pharmaceutical Sciences

448 Mellon Hall
T 412.396.1102
F 412.396.4660 
andersonca@duq.edu

Drennen

James K. Drennen III, Ph.D.

Associate Professor

453 Mellon Hall
T 412.396.5520
F 412.39631168
drennen@duq.edu

Meng

Wilson Meng, Ph.D.

Associate Professor of Pharmaceutical Sciences

413 Mellon Hall
T 412.396.6366
F 412.396.4660
meng@duq.edu

no-photo

Benoit Igne, Ph.D.

Industrial Research Coordinator

410 C Mellon Hall

Accomplishments
  • Hoffman LaRoche awarded the Center $50,000 in 2007-2008 for "Application of NIR Chemical Imaging in Characterization of Tablet Film Coating."
  • Innovation Works awarded the Center $25,000 for the construction of a tunable laser-based process imaging system
  • TeraView, Ltd., has granted DCPT the use of a terahertz imager since 2005 in a research collaboration that involves DCPT faculty and students performing instrument performance evaluation and application development.
  • VTT, a Finnish engineering firm, is assisting DCPT with the construction of a high-speed laser-based chemical imaging system and other devices. DCPT has signed an agreement with VTT that will place two VTT engineers in the DCPT during June 2007 – January 2009, for the purpose of constructing and evaluating instrumentation, cross training, and building a scientific relationship.
  • The Federal Drug Administration (FDA) and DCPT provided a three-day QbD/PAT training session for 38 investigators and reviewers with didactic and laboratory experiences for FDA staff. Additional training sessions occurred during the 2007-2008 semesters at FDA sites in Rockville, MD. Participants included Drs. Anderson, Cogdill, Wildfong and Drennen. Additionally, pharmaceutics graduate students participated in the laboratory component of the on-site training session.
  • Mylan Labs, Inc., collaborated with DCPT to provide Basic Pharmaceutics Principles training courses.
  • DCPT published 14 scientific papers in peer-reviewed journals and delivered 11 scientific podium presentations and 2 poster presentations.